Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Eden Research ( (GB:EDEN) ) has provided an announcement.
Eden Research has appointed Andermatt Kenya Limited as its exclusive distribution partner for Mevalone® in Kenya, aiming to enhance sales in a region with a diverse agricultural sector. This partnership is expected to leverage Andermatt’s extensive network and expertise in sustainable crop protection, capitalizing on Kenya’s significant export market for fruits, vegetables, and cut flowers, and addressing challenges posed by unpredictable weather conditions and fungal outbreaks.
More about Eden Research
Eden Research plc is a leader in sustainable biopesticide and biocontrol technology. The company focuses on developing products like Mevalone®, a biofungicide designed to prevent and treat fungal pathogens on high-value crops using proprietary natural terpene chemistry and yeast-based microencapsulation technology.
YTD Price Performance: -27.85%
Average Trading Volume: 693,553
Technical Sentiment Signal: Buy
Current Market Cap: £15.2M
See more data about EDEN stock on TipRanks’ Stock Analysis page.